Fresenius Kabi Recalls Tyenne Injection Due to Glass Particles
Fresenius Kabi is recalling Tyenne (tocilizumab-aazg) injection vials because an internal investigation found the presence of glass particles.
- Product
- TYENNE — TYENNE (TOCILIZUMAB-AAZG)
- Category
- Drug
- Distribution
- Distributed nationwide